BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khajeh E, Moghadam AD, Eslami P, Ali-hasan-al-saegh S, Ramouz A, Shafiei S, Ghamarnejad O, Dezfouli SA, Rupp C, Springfeld C, Carvalho C, Probst P, Mousavizadeh SM, Mehrabi A. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09192-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Newman CB. Safety of Statins and Nonstatins for Treatment of Dyslipidemia. Endocrinology and Metabolism Clinics of North America 2022. [DOI: 10.1016/j.ecl.2022.01.004] [Reference Citation Analysis]
2 Sung F, Yeh Y, Muo C, Hsu C, Tsai W, Hsu Y. Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study. Cancers 2022;14:825. [DOI: 10.3390/cancers14030825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]